• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
and Co-producing Bacteremia: First Case in Korea.以及共同导致菌血症:韩国首例病例。
Infect Chemother. 2019 Dec;51(4):399-404. doi: 10.3947/ic.2019.51.4.399. Epub 2019 Oct 29.
2
Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.重症监护病房患者中由耐多药鲍曼不动杆菌或产碳青霉烯酶肺炎克雷伯菌引起的感染性休克比较。
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.02562-17. Print 2018 Jun.
3
Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: Emergence of hypermucoviscous ST25 and high-risk clone ST307.阿根廷产 KPC 肺炎克雷伯菌的流行情况变化:高黏液性 ST25 和高风险克隆 ST307 的出现。
J Glob Antimicrob Resist. 2019 Sep;18:238-242. doi: 10.1016/j.jgar.2019.06.005. Epub 2019 Jun 13.
4
A 4.5-Year Within-Patient Evolution of a Colistin-Resistant Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Sequence Type 258.耐黏菌素肺炎克雷伯菌碳青霉烯酶-producing K. pneumoniae 序列型 258 的 4.5 年患者内进化
Clin Infect Dis. 2018 Oct 15;67(9):1388-1394. doi: 10.1093/cid/ciy293.
5
Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.产碳青霉烯酶肺炎克雷伯菌导致 ICU 脓毒性休克患者结局的预测因素。
Clin Microbiol Infect. 2016 May;22(5):444-50. doi: 10.1016/j.cmi.2016.01.016. Epub 2016 Feb 3.
6
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study.多中心病例对照对照研究:产碳青霉烯酶 KPC 肺炎克雷伯菌血流感染的危险因素。
Clin Microbiol Infect. 2015 Dec;21(12):1106.e1-8. doi: 10.1016/j.cmi.2015.08.001. Epub 2015 Aug 14.
7
An Update of the Evolving Epidemic of blaKPC Carrying Klebsiella pneumoniae in Sicily, Italy, 2014: Emergence of Multiple Non-ST258 Clones.2014年意大利西西里岛携带blaKPC的肺炎克雷伯菌流行情况的最新进展:多种非ST258克隆株的出现
PLoS One. 2015 Jul 15;10(7):e0132936. doi: 10.1371/journal.pone.0132936. eCollection 2015.
8
Clonal replacement of epidemic KPC-producing Klebsiella pneumoniae in a hospital in China.中国一家医院中流行的产KPC肺炎克雷伯菌的克隆替代现象
BMC Infect Dis. 2017 May 23;17(1):363. doi: 10.1186/s12879-017-2467-9.
9
Two Distinct Genotypes of KPC-2-Producing Isolates from South Korea.来自韩国的产KPC-2分离株的两种不同基因型。
Antibiotics (Basel). 2021 Jul 26;10(8):911. doi: 10.3390/antibiotics10080911.
10
Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.重症监护病房中产KPC肺炎克雷伯菌血流感染患者的感染危险因素及死亡预测因素。
Scand J Infect Dis. 2014 Sep;46(9):642-8. doi: 10.3109/00365548.2014.923106. Epub 2014 Jul 14.

引用本文的文献

1
A Review on Colistin Resistance: An Antibiotic of Last Resort.关于黏菌素耐药性的综述:一种最后的抗生素
Microorganisms. 2024 Apr 11;12(4):772. doi: 10.3390/microorganisms12040772.
2
Molecular Mechanism of Polymyxin Resistance in Multidrug-Resistant and Isolates from Henan Province, China: A Multicenter Study.中国河南省多药耐药鲍曼不动杆菌分离株中多粘菌素耐药的分子机制:一项多中心研究
Infect Drug Resist. 2021 Jul 12;14:2657-2666. doi: 10.2147/IDR.S314490. eCollection 2021.
3
Identification of an extensively drug-resistant Escherichia coli clinical strain harboring mcr-1 and bla in Korea.在韩国发现一株携带 mcr-1 和 bla 的广泛耐药性大肠杆菌临床株。
J Antibiot (Tokyo). 2020 Dec;73(12):852-858. doi: 10.1038/s41429-020-0350-1. Epub 2020 Jul 14.

本文引用的文献

1
Colistin-resistant Klebsiella pneumoniae co-harboring KPC and MCR-1 in a Hematopoietic Stem Cell Transplantation Unit.在一家造血干细胞移植病房中同时携带KPC和MCR-1的耐黏菌素肺炎克雷伯菌
Bone Marrow Transplant. 2019 Jul;54(7):1118-1120. doi: 10.1038/s41409-018-0416-x. Epub 2018 Nov 30.
2
Detection of mcr-1 Plasmids in Enterobacteriaceae Isolates From Human Specimens: Comparison With Those in Escherichia coli Isolates From Livestock in Korea.从人体标本中分离的肠杆菌科细菌中 mcr-1 质粒的检测:与韩国家畜源大肠杆菌分离株的比较。
Ann Lab Med. 2018 Nov;38(6):555-562. doi: 10.3343/alm.2018.38.6.555.
3
mcr-1 Gene Has No Effect on Colistin Resistance When It Coexists with Inactivated mgrB Gene in Klebsiella pneumoniae.在肺炎克雷伯菌中,当mcr - 1基因与失活的mgrB基因共存时,其对黏菌素耐药性无影响。
Microb Drug Resist. 2018 Oct;24(8):1117-1120. doi: 10.1089/mdr.2017.0291. Epub 2018 May 16.
4
Carbapenemase Producers in South Korea between 2013 and 2015.2013年至2015年韩国的碳青霉烯酶生产者
Front Microbiol. 2018 Jan 25;9:56. doi: 10.3389/fmicb.2018.00056. eCollection 2018.
5
Acquisition of the mcr-1 gene by a high-risk clone of KPC-2-producing Klebsiella pneumoniae ST437/CC258, Brazil.巴西一株产KPC-2的肺炎克雷伯菌ST437/CC258高危克隆株获得mcr-1基因。
Diagn Microbiol Infect Dis. 2018 Feb;90(2):132-133. doi: 10.1016/j.diagmicrobio.2017.09.016. Epub 2017 Oct 5.
6
A Survival Analysis of Gastric or Colorectal Cancer Patients Treated With Surgery: Comparison of Capital and a Non-capital City.接受手术治疗的胃癌或结直肠癌患者的生存分析:首都城市与非首都城市的比较
J Prev Med Public Health. 2017 Sep;50(5):283-293. doi: 10.3961/jpmph.17.043.
7
Detection and genetic features of MCR-1-producing plasmid in human Escherichia coli infection in South Korea.韩国人类大肠杆菌感染中产MCR-1质粒的检测及遗传特征
Diagn Microbiol Infect Dis. 2017 Oct;89(2):158-160. doi: 10.1016/j.diagmicrobio.2017.06.020. Epub 2017 Jul 2.
8
Detection of the plasmid-mediated mcr-1 gene in clinical KPC-2-producing Escherichia coli isolates in Brazil.在巴西临床产KPC-2的大肠杆菌分离株中检测质粒介导的mcr-1基因。
Int J Antimicrob Agents. 2017 Aug;50(2):282-284. doi: 10.1016/j.ijantimicag.2017.05.003. Epub 2017 Jun 1.
9
Emergence of the Plasmid-Mediated Gene in Clinical KPC-2-Producing Klebsiella pneumoniae Sequence Type 392 in Brazil.巴西临床产KPC-2型肺炎克雷伯菌序列型392中质粒介导基因的出现。
Antimicrob Agents Chemother. 2017 Jun 27;61(7). doi: 10.1128/AAC.00317-17. Print 2017 Jul.
10
Carbapenem-resistant Enterobacteriaceae: Prevalence and Risk Factors in a Single Community-Based Hospital in Korea.耐碳青霉烯类肠杆菌科细菌:韩国一家社区医院的患病率及危险因素
Infect Chemother. 2016 Sep;48(3):166-173. doi: 10.3947/ic.2016.48.3.166. Epub 2016 Sep 8.

以及共同导致菌血症:韩国首例病例。

and Co-producing Bacteremia: First Case in Korea.

作者信息

Park Ji Young, Heo Sang Taek, Kwon Ki Tae, Song Do Young, Lee Kwang Jun, Choi Ji Ae

机构信息

Department of Pathology, School of Medicine, Kyungpook National University, Daegu, Korea.

Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea.

出版信息

Infect Chemother. 2019 Dec;51(4):399-404. doi: 10.3947/ic.2019.51.4.399. Epub 2019 Oct 29.

DOI:10.3947/ic.2019.51.4.399
PMID:31668026
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6940374/
Abstract

carbapenemase-producing (KPC-KP) has been disseminating nationwide due to clonal spread and is taking a serious action at the national level in Korea. The mobilized colistin resistance () gene confers plasmid-mediated resistance to colistin and is known to be capable of horizontal transfer between different strains of a bacterial species. We have experienced a fatal case of the patient who developed -possessing, ST307/Tn4401a[] bacteremia in the community of non-capital region after being diagnosed as pancreatic cancer with multiple liver metastases and treated in the capital region. The ST307/Tn4401a[] was the most commonly disseminated clone in Korea. Our strain is the first MCR1 and KPC2 co-producing in Korea and our case is the critical example that the multi-drug resistant clone can cause inter-regional spread and the community-onset fatal infections. Fortunately, our patient was admitted to the intensive care unit on the day of visit, and the contact precaution was well maintained throughout and KPC-KP was not spread to other patients. The high risk patients for KPC-KP need to be screened actively, detected rapidly and preemptively isolated to prevent outbreak of KPC-KP. Inter-facility communications are essential and the nationwide epidemiologic data of KPC-KP should be analyzed and reported regularly to prevent spread of KPC-KP. The prompt identification of species and antimicrobial susceptibilities for successful treatment against KPC-KP should be emphasized as well.

摘要

产碳青霉烯酶(KPC-KP)因克隆传播已在全国范围内扩散,韩国正在国家层面采取严肃行动。可移动的黏菌素耐药()基因赋予质粒介导的黏菌素耐药性,已知其能够在细菌物种的不同菌株之间进行水平转移。我们经历了一例致命病例,该患者在首都地区被诊断为胰腺癌伴多发肝转移并接受治疗后,在非首都地区社区发生了携带、ST307/Tn4401a[]的菌血症。ST307/Tn4401a[]是韩国最常见的传播克隆。我们的菌株是韩国首例同时产生MCR1和KPC2的菌株,我们的病例是多药耐药克隆可导致跨区域传播和社区发病致命感染的关键例证。幸运的是,我们的患者在就诊当天被收入重症监护病房,且始终严格保持接触预防措施,KPC-KP未传播给其他患者。需要积极筛查KPC-KP的高危患者,快速检测并抢先隔离,以预防KPC-KP的暴发。机构间沟通至关重要,应定期分析和报告KPC-KP的全国流行病学数据,以防止KPC-KP的传播。同时,应强调及时鉴定菌种和抗菌药物敏感性,以成功治疗KPC-KP。